-
EVALUATING THE IMPACT OF THE INFLATION REDUCTION ACT OUT-OF-POCKET CAPS ON PATIENT ASSISTANCE FUNDS EFFICIENCY AND COVERAGE EXPANSION
Mar 18, 2026, 21:38 PM -
INCORPORATING SPILLOVER EFFECTS IN COST-EFFECTIVENESS ANALYSIS: A CASE STUDY FOR FIRST LINE TREATMENT OF METASTATIC (STAGE IV) NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF LAZERTINIB-AMIVANTAMAB COMPARED TO OSIMERTINIB FOR NON-SMALL CELL LUNG CANCER: A 5-YEAR PARTITIONED SURVIVAL MODEL
Mar 18, 2026, 21:38 PM -
MIND THE GAP: ARTIFICIAL INTELLIGENCE (AI) POWERED ANALYSIS OF DECISION DRIVERS WITHIN ULTRA-RARE DISEASE/HST NICE TECHNOLOGY APPRAISALS
Mar 18, 2026, 21:38 PM -
COULD OPERATING-ROOM TIME DIFFERENCES FOR LITHOTRIPSY BE AN INDICATOR OF HEALTHCARE ACCESS?
Mar 18, 2026, 21:38 PM -
DISTANCE FROM HEALTH CARE FACILITY AND OTHER VARIABLES IMPACT TIME TO CELIAC DISEASE DIAGNOSIS
Mar 18, 2026, 21:38 PM -
COST COMPARISON OF ATEZOLIZUMAB IN CANADA FOR THE FIRST-LINE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS WITH HIGH PROGRAMMED DEATH-LIGAND 1 EXPRESSION
Mar 18, 2026, 21:38 PM -
TEMPORAL TRENDS AND DETERMINANTS OF AORTIC VALVE REPLACEMENT IN PATIENTS WITH ASYMPTOMATIC SEVERE AORTIC STENOSIS
Mar 18, 2026, 21:38 PM -
USE OF REAL-WORLD EVIDENCE ON US BRANDED HCP DRUG WEBSITES: AN AI-ENABLED CONTENT ANALYSIS
Mar 18, 2026, 21:38 PM -
PROJECT ORBIS: DOES REGULATORY ACCELERATION TRANSLATE TO FASTER GLOBAL PATIENT ACCESS?
Mar 18, 2026, 21:38 PM -
COMPARISON OF SAMPLING STRATEGIES TO ADDRESS SEVERE DATA IMBALANCE AND COMPUTATIONAL BENCHMARKING FOR TIME-TO-EVENT PREDICTIVE MODEL DEVELOPMENT ACROSS LOCAL AND HIGH-PERFORMANCE COMPUTING ENVIRONMENTS: PREDICTION OF ALCOHOL USE DISORDER AND OPIOID...
Mar 18, 2026, 21:38 PM -
WHEN ADHERENCE ESTIMATES DIFFER: THE IMPACT OF DATA SOURCE AND GAP HANDLING IN REAL-WORLD MEDICATION USE ASSESSMENT
Mar 18, 2026, 21:38 PM -
ESTIMATINGTHE EFFECTS OF VARIED VACCINATION COVERAGE LEVELS ON A MEASLES OUTBREAK IN AN ISOLATED POPULATION
Mar 18, 2026, 21:38 PM -
REAL-WORLD COMPARISON OF OLANZAPINE/SAMIDORPHAN VS OLANZAPINE: AN ASSESSMENT OF TREATMENT PATTERNS AND ACUTE CARE EVENTS AMONG PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER
Mar 18, 2026, 21:38 PM -
WHEN TRIALS FALL SHORT: LEVERAGING REAL-WORLD EVIDENCE TO ADVANCE PRECISION THERAPIES
Mar 18, 2026, 21:38 PM -
REDUCING DECISION UNCERTAINTY IN ULTRA-RARE PEDIATRIC CONDITIONS: A DELPHI-BASED APPROACH TO INFORM HTA AND PRICING & REIMBURSEMENT FOR NON-DYSTROPHIC MYOTONIAS
Mar 18, 2026, 21:38 PM -
REAL-WORLD USE OF GENERATIVE AI ASSISTANT TOOLS ACROSS HEALTH ECONOMICS AND OUTCOMES RESEARCH WORKFLOWS: A SCOPING REVIEW
Mar 18, 2026, 21:38 PM -
COST SAVINGS OF AN AI-ENABLED DIGITAL TWIN PROGRAM IN PREDIABETES AND HEALTHY WEIGHT MANAGEMENT
Mar 18, 2026, 21:38 PM -
FACTORS ASSOCIATED WITH PREOPERATIVE HEALTH-RELATED QUALITY OF LIFE IN PATIENTSUNDERGOING SURGERYFOR DEGENERATIVE LUMBAR SPINE CONDITIONS: A CROSS-SECTIONAL EQ-5D STUDYIN A MULTI-ETHNIC ASIAN POPULATION
Mar 18, 2026, 21:38 PM -
EFFECT OF MENTAL HEALTH PARITY AND ADDICTION EQUITY ACT (MHPAEA) ON MENTAL HEALTH CARE UTILIZATION
Mar 18, 2026, 21:38 PM
